Search Results for: ABIO
Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions...
Published:
The NDX Network (XDC) has emerged as a promising player in the blockchain ecosystem, and it has been capturing the attention of investors with its focus on enterprise-grade solutions. However,...
Published:
Tether (USDT) is a popular stablecoin in the crypto market. USDT is connected to the US Dollar and its strength has made it one of the investment choices with a high demand in the crypto market. One...
Published:
Best-selling author and personal finance expert Dave Ramsey has been on a mission to help people transform their relationship with money and get out of debt. With his highly successful book, “The...
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Everyone understands the excitement you get from those crisp, clean vacuum lines after a good cleaning. Obviously, some vacuums do it better than others. Vacuums are no small investment, particularly...
Published:
World War II shaped the course of human history more than any conflict in recent memory. It shaped the world order as we know it today and much of the world’s military technology. Small arms were...
Published:
Chrysler and GM (GM) propose closing 3,000 dealers in an effort to save money by narrowing down their distribution networks. Some of the larger dealers probably employ 100 people. In an economy that...
Published:
Last Updated:
At 60, if your finances are in a shambles, take heart. You’re in good company. However, with a few of Dave Ramsey’s tweaks, you can get back on the right track. After experiencing a downturn in...
Published:
Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.
Published:
Last Updated:
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
Published:
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Published:
Last Updated:
Abiomed reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.
Published:
Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm...
Published:
Last Updated: